Articles by Jill Wechsler - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jill Wechsler

Through the Looking Glass

Mar 1, 2009

The latest buzzword in pharma is "transparency"

Securing Savings

Feb 1, 2009

A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.

FDA Turnaround Time

Jan 1, 2009

Will more resourches and new leadership fix FDA, or is a major overhaul in order?

Challenge and Challenges

Dec 1, 2008

To expand health coverage amid an economic crisis, Obama will be looking hard for ways to cut costs

Resolving Conflicting Interests

Financial links to biomedical researchers may lead to stiffer disclosure rules for pharma and challenges for research partnerships
Nov 1, 2008

As Congress moves to curb industry influence, support for med ed is waning

Part D Under Attack

Oct 1, 2008

Congressional leaders ready campaign to curb Medicare drug plans.

Foreign Affairs

Sep 1, 2008

FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches

Can Sentinel Save Drug Development?

Aug 1, 2008

FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon

Smooth Sailing for Orphans

Rare disease treatments are riding high as patient advocates, pharma companies, and government officials celebrate the ODA's 25th anniversary
Jul 1, 2008

Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary

ADVERTISEMENT

Click here